IDF<source>Diabetes Atlas</source><year>2009</year><issue>4th edn</issue><other>Brussels</other><publisher>International Diabetes Federation</publisher>
IDF Clinical Guidelines Task Force<source>Global Guideline for Type 2 Diabetes</source><year>2005</year><other>Brussels</other><publisher>International Diabetes Federation</publisher>
NICE<source>Type 2 Diabetes. The Management of Type 2 Diabetes</source><year>2008</year><other>London</other><publisher>National Institute for Health and Clinical Excellence</publisher>NICE clinical guideline 66
American Diabetes Association<title>Standards of medical care in diabetes&#8212;2010</title><source>Diabetes Care</source><year>2010</year><volume>33</volume><fpage>S11</fpage><lpage>S61</lpage>
<author><surname>Gray</surname> <given-names>A</given-names> </author><author><surname>Raikou</surname> <given-names>M</given-names> </author><author><surname>McGuire</surname> <given-names>A</given-names> </author><author><surname>Fenn</surname> <given-names>P</given-names> </author><author><surname>Stevens</surname> <given-names>R</given-names> </author><author><surname>Cull</surname> <given-names>C</given-names> </author><title>Cost-effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). UK Prospective Diabetes Study Group</title><source>Br Med J</source><year>2000</year><volume>320</volume><fpage>1373</fpage><lpage>1378</lpage>
<author><surname>Huang</surname> <given-names>ES</given-names> </author><author><surname>Zhang</surname> <given-names>Q</given-names> </author><author><surname>Brown</surname> <given-names>SE</given-names> </author><author><surname>Drum</surname> <given-names>ML</given-names> </author><author><surname>Meltzer</surname> <given-names>DO</given-names> </author><author><surname>Chin</surname> <given-names>MH</given-names> </author><title>The cost-effectiveness of improving diabetes care in US federally qualified community health centers</title><source>Health Serv Res</source><year>2007</year><volume>42</volume><fpage>2174</fpage><lpage>2193</lpage>
<author><surname>Holman</surname> <given-names>RR</given-names> </author><author><surname>Paul</surname> <given-names>SK</given-names> </author><author><surname>Bethel</surname> <given-names>MA</given-names> </author><author><surname>Matthews</surname> <given-names>DR</given-names> </author><author><surname>Neil</surname> <given-names>HA</given-names> </author><title>10-year follow-up of intensive glucose control in type 2 diabetes</title><source>N Engl J Med</source><year>2008</year><volume>359</volume><fpage>1577</fpage><lpage>1589</lpage>
<author><surname>Gaede</surname> <given-names>P</given-names> </author><author><surname>Lund-Andersen</surname> <given-names>H</given-names> </author><author><surname>Parving</surname> <given-names>HH</given-names> </author><author><surname>Pedersen</surname> <given-names>O</given-names> </author><title>Effect of a multifactorial intervention on mortality in type 2 diabetes</title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>580</fpage><lpage>591</lpage>
<author><surname>Stratton</surname> <given-names>IM</given-names> </author><author><surname>Adler</surname> <given-names>AI</given-names> </author><author><surname>Neil</surname> <given-names>HA</given-names> </author><author><surname>Matthews</surname> <given-names>DR</given-names> </author><author><surname>Manley</surname> <given-names>SE</given-names> </author><author><surname>Cull</surname> <given-names>CA</given-names> </author><title>Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study</title><source>Br Med J</source><year>2000</year><volume>321</volume><fpage>405</fpage><lpage>412</lpage>
UKPDS Research Group<title>Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group</title><source>Lancet</source><year>1998</year><volume>352</volume><fpage>837</fpage><lpage>853</lpage>
<author><surname>Zoungas</surname> <given-names>S</given-names> </author><author><surname>de Galan</surname> <given-names>BE</given-names> </author><author><surname>Ninomiya</surname> <given-names>T</given-names> </author><author><surname>Grobbee</surname> <given-names>D</given-names> </author><author><surname>Hamet</surname> <given-names>P</given-names> </author><author><surname>Heller</surname> <given-names>S</given-names> </author><title>Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial</title><source>Diabetes Care</source><year>2009</year><volume>32</volume><fpage>2068</fpage><lpage>2074</lpage>
American Diabetes Association<title>Diagnosis and classification of diabetes mellitus</title><source>Diabetes Care</source><year>2010</year><volume>33</volume><fpage>S62</fpage><lpage>S69</lpage>
<author><surname>Geistanger</surname> <given-names>A</given-names> </author><author><surname>Arends</surname> <given-names>S</given-names> </author><author><surname>Berding</surname> <given-names>C</given-names> </author><author><surname>Hoshino</surname> <given-names>T</given-names> </author><author><surname>Jeppsson</surname> <given-names>JO</given-names> </author><author><surname>Little</surname> <given-names>R</given-names> </author><title>Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan and Sweden</title><source>Clin Chem</source><year>2008</year><volume>54</volume><fpage>1379</fpage><lpage>1385</lpage>
<author><surname>Duke</surname> <given-names>SA</given-names> </author><author><surname>Colagiuri</surname> <given-names>S</given-names> </author><author><surname>Colagiuri</surname> <given-names>R</given-names> </author><title>Individual patient education for people with type 2 diabetes mellitus</title><source>Cochrane Database Syst Rev</source><year>2009</year><volume>1</volume><fpage>CD005268</fpage>
<author><surname>Ellis</surname> <given-names>SE</given-names> </author><author><surname>Speroff</surname> <given-names>T</given-names> </author><author><surname>Dittus</surname> <given-names>RS</given-names> </author><author><surname>Brown</surname> <given-names>A</given-names> </author><author><surname>Pichert</surname> <given-names>JW</given-names> </author><author><surname>Elasy</surname> <given-names>TA</given-names> </author><title>Diabetes patient education: a meta-analysis and meta-regression</title><source>Patient Educ Couns</source><year>2004</year><volume>52</volume><fpage>97</fpage><lpage>105</lpage>
<author><surname>Loveman</surname> <given-names>E</given-names> </author><author><surname>Frampton</surname> <given-names>GK</given-names> </author><author><surname>Clegg</surname> <given-names>AJ</given-names> </author><title>The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review</title><source>Health Technol Assess</source><year>2008</year><volume>12</volume><fpage>1</fpage><lpage>136</lpage>
<author><surname>Peyrot</surname> <given-names>M</given-names> </author><author><surname>Rubin</surname> <given-names>RR</given-names> </author><author><surname>Lauritzen</surname> <given-names>T</given-names> </author><author><surname>Snoek</surname> <given-names>FJ</given-names> </author><author><surname>Matthews</surname> <given-names>DR</given-names> </author><author><surname>Skovlund</surname> <given-names>SE</given-names> </author><title>Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study</title><source>Diabet Med</source><year>2005</year><volume>22</volume><fpage>1379</fpage><lpage>1385</lpage>
<author><surname>Simmons</surname> <given-names>D</given-names> </author><author><surname>Lillis</surname> <given-names>S</given-names> </author><author><surname>Swan</surname> <given-names>J</given-names> </author><author><surname>Haar</surname> <given-names>J</given-names> </author><title>Discordance in perceptions of barriers to diabetes care between patients and primary care and secondary care</title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>490</fpage><lpage>495</lpage>
<author><surname>Kraushaar</surname> <given-names>LE</given-names> </author><author><surname>Kr&#228;mer</surname> <given-names>A</given-names> </author><title>Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention</title><source>BMC Public Health</source><year>2009</year><volume>9</volume><fpage>64</fpage>
<author><surname>Davies</surname> <given-names>MJ</given-names> </author><author><surname>Heller</surname> <given-names>S</given-names> </author><author><surname>Skinner</surname> <given-names>TC</given-names> </author><author><surname>Campbell</surname> <given-names>MJ</given-names> </author><author><surname>Carey</surname> <given-names>ME</given-names> </author><author><surname>Cradock</surname> <given-names>S</given-names> </author><title>Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial</title><source>Br Med J</source><year>2008</year><volume>336</volume><fpage>491</fpage><lpage>495</lpage>
<author><surname>Stettler</surname> <given-names>C</given-names> </author><author><surname>Allemann</surname> <given-names>S</given-names> </author><author><surname>J&#252;ni</surname> <given-names>P</given-names> </author><author><surname>Cull</surname> <given-names>CA</given-names> </author><author><surname>Holman</surname> <given-names>RR</given-names> </author><author><surname>Egger</surname> <given-names>M</given-names> </author><title>Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials</title><source>Am Heart J</source><year>2006</year><volume>152</volume><fpage>27</fpage><lpage>38</lpage>
<author><surname>Kirkman</surname> <given-names>MS</given-names> </author><author><surname>Williams</surname> <given-names>SR</given-names> </author><author><surname>Caffrey</surname> <given-names>HH</given-names> </author><author><surname>Marrero</surname> <given-names>DG</given-names> </author><title>Impact of a program to improve adherence to diabetes guidelines by primary care physicians</title><source>Diabetes Care</source><year>2002</year><volume>25</volume><fpage>1946</fpage><lpage>1951</lpage>
<author><surname>Tabrizi</surname> <given-names>JS</given-names> </author><author><surname>O'Rourke</surname> <given-names>PK</given-names> </author><author><surname>Wilson</surname> <given-names>AJ</given-names> </author><author><surname>Coyne</surname> <given-names>ET</given-names> </author><title>Service quality for Type 2 diabetes in Australia: the patient perspective</title><source>Diabet Med</source><year>2008</year><volume>25</volume><fpage>612</fpage><lpage>617</lpage>
<author><surname>Guldberg</surname> <given-names>TL</given-names> </author><author><surname>Lauritzen</surname> <given-names>T</given-names> </author><author><surname>Kristensen</surname> <given-names>JK</given-names> </author><author><surname>Vedsted</surname> <given-names>P</given-names> </author><title>The effect of feedback to general practitioners on quality of care for people with type 2 diabetes. A systematic review of the literature</title><source>BMC Fam Pract</source><year>2009</year><volume>10</volume><fpage>30</fpage>
<author><surname>Duran</surname> <given-names>A</given-names> </author><author><surname>Runkle</surname> <given-names>I</given-names> </author><author><surname>Matia</surname> <given-names>P</given-names> </author><author><surname>de Miguel</surname> <given-names>MP</given-names> </author><author><surname>Garrido</surname> <given-names>S</given-names> </author><author><surname>Cervera</surname> <given-names>E</given-names> </author><title>Family physician and endocrinologist coordination as the basis for diabetes care in clinical practice</title><source>BMC Endocr Disord</source><year>2008</year><volume>8</volume><fpage>9</fpage>
<author><surname>Grant</surname> <given-names>RW</given-names> </author><author><surname>Meigs</surname> <given-names>JB</given-names> </author><title>Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction</title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>479</fpage><lpage>484</lpage>
The Diabetes and Nutrition Study Group of the Spanish Diabetes Association (GSEDNu)<title>Diabetes Nutrition and Complications Trial: adherence to the ADA nutritional recommendations, targets of metabolic control, and onset of diabetes complications. A 7-year, prospective, population-based, observational multi-center study</title><source>J Diabetes Complications</source><year>2006</year><volume>20</volume><fpage>361</fpage><lpage>366</lpage>
The Diabetes and Nutrition Study Group of the Spanish Diabetes Association (GSEDNu)<title>Diabetes Nutrition and Complications Trial (DNCT). Diet and risk of microangiopathy progression: the role of polyunsaturated fatty acids and monounsaturated fatty acids consumption</title><source>Obes Metab</source><year>2006</year><volume>2</volume><fpage>6</fpage><lpage>12</lpage>
<author><surname>da Silva</surname> <given-names>R</given-names> </author><author><surname>Bach-Faig</surname> <given-names>A</given-names> </author><author><surname>Raid&#243; Quintana</surname> <given-names>B</given-names> </author><author><surname>Buckland</surname> <given-names>G</given-names> </author><author><surname>Vaz de Almeida</surname> <given-names>MD</given-names> </author><author><surname>Serra-Majem</surname> <given-names>L</given-names> </author><title>Worldwide variation of adherence to the Mediterranean diet, in 1961&#8211;1965 and 2000&#8211;2003</title><source>Public Health Nutr</source><year>2009</year><volume>12</volume><fpage>1676</fpage><lpage>1684</lpage>